133 related articles for article (PubMed ID: 34249927)
1. Corrigendum: Cathepsin D Variants Associated With Neurodegenerative Diseases Show Dysregulated Functionality and Modified α-Synuclein Degradation Properties.
Bunk J; Prieto Huarcaya S; Drobny A; Dobert JP; Walther L; Rose-John S; Arnold P; Zunke F
Front Cell Dev Biol; 2021; 9():671532. PubMed ID: 34249927
[TBL] [Abstract][Full Text] [Related]
2. Cathepsin D Variants Associated With Neurodegenerative Diseases Show Dysregulated Functionality and Modified α-Synuclein Degradation Properties.
Bunk J; Prieto Huarcaya S; Drobny A; Dobert JP; Walther L; Rose-John S; Arnold P; Zunke F
Front Cell Dev Biol; 2021; 9():581805. PubMed ID: 33681191
[TBL] [Abstract][Full Text] [Related]
3. Lysosomal response in relation to α-synuclein pathology differs between Parkinson's disease and multiple system atrophy.
Puska G; Lutz MI; Molnar K; Regelsberger G; Ricken G; Pirker W; Laszlo L; Kovacs GG
Neurobiol Dis; 2018 Jun; 114():140-152. PubMed ID: 29505813
[TBL] [Abstract][Full Text] [Related]
4. Haploinsufficiency of cathepsin D leads to lysosomal dysfunction and promotes cell-to-cell transmission of α-synuclein aggregates.
Bae EJ; Yang NY; Lee C; Kim S; Lee HJ; Lee SJ
Cell Death Dis; 2015 Oct; 6(10):e1901. PubMed ID: 26448324
[TBL] [Abstract][Full Text] [Related]
5. Enzyme replacement therapy with recombinant pro-CTSD (cathepsin D) corrects defective proteolysis and autophagy in neuronal ceroid lipofuscinosis.
Marques ARA; Di Spiezio A; Thießen N; Schmidt L; Grötzinger J; Lüllmann-Rauch R; Damme M; Storck SE; Pietrzik CU; Fogh J; Bär J; Mikhaylova M; Glatzel M; Bassal M; Bartsch U; Saftig P
Autophagy; 2020 May; 16(5):811-825. PubMed ID: 31282275
[TBL] [Abstract][Full Text] [Related]
6. Cysteine cathepsins are essential in lysosomal degradation of α-synuclein.
McGlinchey RP; Lee JC
Proc Natl Acad Sci U S A; 2015 Jul; 112(30):9322-7. PubMed ID: 26170293
[TBL] [Abstract][Full Text] [Related]
7. Parkinson's disease: acid-glucocerebrosidase activity and alpha-synuclein clearance.
Blanz J; Saftig P
J Neurochem; 2016 Oct; 139 Suppl 1():198-215. PubMed ID: 26860955
[TBL] [Abstract][Full Text] [Related]
8. Glucocerebrosidase activity, cathepsin D and monomeric α-synuclein interactions in a stem cell derived neuronal model of a PD associated GBA1 mutation.
Yang SY; Gegg M; Chau D; Schapira A
Neurobiol Dis; 2020 Feb; 134():104620. PubMed ID: 31634558
[TBL] [Abstract][Full Text] [Related]
9. LRRK2 G2019S Mutation Inhibits Degradation of α-Synuclein in an In Vitro Model of Parkinson's Disease.
Hu D; Niu JY; Xiong J; Nie SK; Zeng F; Zhang ZH
Curr Med Sci; 2018 Dec; 38(6):1012-1017. PubMed ID: 30536063
[TBL] [Abstract][Full Text] [Related]
10. Lysosomal trafficking defects link Parkinson's disease with Gaucher's disease.
Wong YC; Krainc D
Mov Disord; 2016 Nov; 31(11):1610-1618. PubMed ID: 27619775
[TBL] [Abstract][Full Text] [Related]
11. Autophagy-lysosome pathway alterations and alpha-synuclein up-regulation in the subtype of neuronal ceroid lipofuscinosis, CLN5 disease.
Adams J; Feuerborn M; Molina JA; Wilden AR; Adhikari B; Budden T; Lee SY
Sci Rep; 2019 Jan; 9(1):151. PubMed ID: 30655561
[TBL] [Abstract][Full Text] [Related]
12. VPS35 dysfunction impairs lysosomal degradation of α-synuclein and exacerbates neurotoxicity in a Drosophila model of Parkinson's disease.
Miura E; Hasegawa T; Konno M; Suzuki M; Sugeno N; Fujikake N; Geisler S; Tabuchi M; Oshima R; Kikuchi A; Baba T; Wada K; Nagai Y; Takeda A; Aoki M
Neurobiol Dis; 2014 Nov; 71():1-13. PubMed ID: 25107340
[TBL] [Abstract][Full Text] [Related]
13. Rotenone impairs autophagic flux and lysosomal functions in Parkinson's disease.
Wu F; Xu HD; Guan JJ; Hou YS; Gu JH; Zhen XC; Qin ZH
Neuroscience; 2015 Jan; 284():900-911. PubMed ID: 25446361
[TBL] [Abstract][Full Text] [Related]
14. Lysosomal cathepsins and their regulation in aging and neurodegeneration.
Stoka V; Turk V; Turk B
Ageing Res Rev; 2016 Dec; 32():22-37. PubMed ID: 27125852
[TBL] [Abstract][Full Text] [Related]
15. Role of the Lysosomal Membrane Protein, CLN3, in the Regulation of Cathepsin D Activity.
Cárcel-Trullols J; Kovács AD; Pearce DA
J Cell Biochem; 2017 Nov; 118(11):3883-3890. PubMed ID: 28390177
[TBL] [Abstract][Full Text] [Related]
16. C-terminal α-synuclein truncations are linked to cysteine cathepsin activity in Parkinson's disease.
McGlinchey RP; Lacy SM; Huffer KE; Tayebi N; Sidransky E; Lee JC
J Biol Chem; 2019 Jun; 294(25):9973-9984. PubMed ID: 31092553
[TBL] [Abstract][Full Text] [Related]
17. Mannose 6-Phosphate Receptor Is Reduced in -Synuclein Overexpressing Models of Parkinsons Disease.
Matrone C; Dzamko N; Madsen P; Nyegaard M; Pohlmann R; Søndergaard RV; Lassen LB; Andresen TL; Halliday GM; Jensen PH; Nielsen MS
PLoS One; 2016; 11(8):e0160501. PubMed ID: 27509067
[TBL] [Abstract][Full Text] [Related]
18. A mutation in the ovine cathepsin D gene causes a congenital lysosomal storage disease with profound neurodegeneration.
Tyynelä J; Sohar I; Sleat DE; Gin RM; Donnelly RJ; Baumann M; Haltia M; Lobel P
EMBO J; 2000 Jun; 19(12):2786-92. PubMed ID: 10856224
[TBL] [Abstract][Full Text] [Related]
19. Genetic modifiers of degeneration in the cathepsin D deficient Drosophila model for neuronal ceroid lipofuscinosis.
Kuronen M; Talvitie M; Lehesjoki AE; Myllykangas L
Neurobiol Dis; 2009 Dec; 36(3):488-93. PubMed ID: 19761846
[TBL] [Abstract][Full Text] [Related]
20. Neuronal Soma-Derived Degradative Lysosomes Are Continuously Delivered to Distal Axons to Maintain Local Degradation Capacity.
Farfel-Becker T; Roney JC; Cheng XT; Li S; Cuddy SR; Sheng ZH
Cell Rep; 2019 Jul; 28(1):51-64.e4. PubMed ID: 31269450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
